Cathie Wood adds to TEM and ILMN but trims stake in Eli Lilly
According to Stocktwits, ARK Invest bought shares of several biotech and genomics firms on Friday while trimming its Eli Lilly position after a strong quarter.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Cathie Wood's ARK Invest made a series of trades across its actively managed ETFs on Friday, adding to healthcare, genomics and crypto-related stocks. Some long-held positions were reduced at the same time, Stocktwits reported.
The most notable purchase was Tempus AI (TEM), where the ARKG and ARKK funds together added about 155,000 shares. Illumina (ILMN) gained 43,130 shares through ARKK. ARKG also increased holdings in Pacific Biosciences, Beam Therapeutics and Arcturus Therapeutics, while ARKK bought another 346,507 shares of Pacific Biosciences.
Among fintech and crypto companies, ARK added to Circle Internet Group (CRCL), Coinbase (COIN) and Robinhood (HOOD). Eli Lilly was sold: ARKK cut 17,626 shares after the drugmaker reported third-quarter results that beat expectations. ARK also reduced CareDx (CDNA), and sold more than 238,000 shares of Bullish (BLSH) across three funds. According to the report, one of the names mentioned fell nearly 7% in Friday's regular session.
why it matters
Trade disclosures like these are published regularly and reflect the moves of individual funds more than a broad market signal. For investors, the point is that Wood's funds keep backing biotech and genomics while reducing exposure to a large drugmaker with strong results.
tags
instruments
sources
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3 — Stocktwits, 31 October 2026 at 05:05 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗